Results 11 to 20 of about 46,120 (196)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE [PDF]

open access: yesРациональная фармакотерапия в кардиологии, 2015
Advantages of metoprolol succinate in patients with chronic heart failure (CHF) are covered. Results of MERIT-HF study are taken as the main evidences. Patterns of the metoprolol succinate use in the treatment of different categories of patients with CHF
O. D. Ostroumova   +2 more
doaj   +4 more sources

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE [PDF]

open access: yesРациональная фармакотерапия в кардиологии, 2016
Clinical and clinicoeconomical studies review is presented as well as results of author’s comparative cost analysis on metoprolol tartrate (Betaloc) and metoprolol succinate (Betaloc ZOK) usage in patients with ischemic heart disease.
M. V. Soura
doaj   +2 more sources

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL? [PDF]

open access: yesРациональная фармакотерапия в кардиологии, 2016
Relationship of metoprolol clinical efficacy with its different salts (tartrate, succinate, fumarate) as well as its presentations (tablets with immediate, controlled or sustained release) is analyzed.
E. V. Kuleshova
doaj   +2 more sources

Use of beta-blockers for the treatment of cardiovascular diseases: focus on metoprolol

open access: yesМедицинский совет, 2015
The article tells about the mechanisms of action of beta-blockers. Pharmacokinetic, pharmacodynamic and interaction properties of metoprolol are discussed.
O. D. Ostroumova, V. M. Fomina
doaj   +2 more sources

Metoprolol succinate extended release/hydrochlorothiazide combination tablets

open access: yesVascular Health and Risk Management, 2007
James W Hainer, Jennifer SuggAstraZeneca LP, Wilmington, DE, USAAbstract: Lowering elevated blood pressure (BP) with drug therapy reduces the risk for catastrophic fatal and nonfatal cardiovascular events such as stroke and myocardial infarction.
James W Hainer, Jennifer Sugg
doaj   +1 more source

Metoprolol succinate 95mg extended-release tablets [PDF]

open access: yes, 2018
Treballs Finals de Grau de Farmàcia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 2018. Tutor: Joaquim Suñer.[eng] A bibliographical research about metoprolol succinate’s pharmacology is conducted, by which the mechanism of
Bordas Pérez, Isaac
core   +6 more sources

The Influence of Polymer Type and Concentration on the Metoprolol Mass Transfer in Extended-Release Tablet of Metoprolol Succinate [PDF]

open access: yesJournal of Chemical and Petroleum Engineering, 2023
Metoprolol has been widely used for controlling high blood pressure, preventing myocardial reinfarction, setting rate changes, setting heart rhythm, treatment of chronic angina and preventing excessive bleeding during surgery.
Parissa Khadivparsi   +6 more
doaj   +1 more source

Evaluation of Khaya gum (Khaya senegalensis) as a polymer in the formulation of floating in situ gels of metoprolol succinate

open access: yesBritish Journal of Pharmacy, 2023
Metoprolol succinate, a β-selective adrenergic blocker, has a short half-life, low bioavailability, and high dosing frequency. In-situ gel drug delivery is a good approach to achieve sustained release for once-daily administration that will prolong drug ...
Adenike Okunlola   +1 more
doaj   +1 more source

CYP2D6 Metabolizer Status and Mortality in Metoprolol Users. [PDF]

open access: yesClin Transl Sci
ABSTRACT Numerous pharmacogenomic (PGx) associations of pharmacokinetics and pharmacodynamics of commonly prescribed medications have been reported. Yet, the evidence supporting their association on survival remains underexamined. We sought to investigate the CYP2D6‐metoprolol association and determine whether the established variability in drug ...
de Denus S   +11 more
europepmc   +2 more sources

Development of Reverse-Phase HPLC Method for Simultaneous Analysis of Metoprolol Succinate and Hydrochlorothiazide in a Tablet Formulation [PDF]

open access: yes, 2010
Purpose: To develop a simple, sensitive and rapid reverse phase HPLC method for the simultaneous analysis of metoprolol succinate and hydrochlorothiazide in a solid dosage form.
Brijesh, S   +5 more
core   +4 more sources

Home - About - Disclaimer - Privacy